Phenolic glycolipid-1 from M. leprae inhibits oxygen free radical production by human mononuclear cells.

[1]  B. Maillère,et al.  Human phagocyte oxidative burst activation by BCG, M. leprae, and atypical mycobacteria: defective activation by M. leprae is not reversed by interferon gamma. , 1989, Cellular immunology.

[2]  P. Aisen,et al.  Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Andersen,et al.  Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae. , 1989, Journal of immunology.

[4]  B. Andersen,et al.  Human phagocytic cell responses to Mycobacterium leprae and Mycobacterium bovis Bacillus Calmette-Guérin. An in vitro comparison of leprosy vaccine components. , 1988, Journal of immunology.

[5]  S. Klebanoff,et al.  The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages , 1988, The Journal of experimental medicine.

[6]  S. Brett,et al.  Interactions of Mycobacterium lepraemurium with resident peritoneal macrophages; phagocytosis and stimulation of the oxidative burst. , 1988, Clinical and experimental immunology.

[7]  I. Nath,et al.  Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type , 1987, The Journal of experimental medicine.

[8]  P. Draper.  Structure of Mycobacterium leprae. , 1986, Leprosy review.

[9]  B. Flageul,et al.  Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. , 1986, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[10]  P. Shankar,et al.  M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. , 1986, Journal of immunology.

[11]  P. Brennan,et al.  Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy. , 1986, The Journal of infectious diseases.

[12]  B. Andersen,et al.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation , 1986, Infection and immunity.

[13]  D. Young,et al.  Detection of phenolic glycolipid I in sera from patients with lepromatous leprosy. , 1985, The Journal of infectious diseases.

[14]  R. Miller,et al.  Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. , 1984, The Journal of infectious diseases.

[15]  J. Convit,et al.  Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid , 1984, Nature.

[16]  D. Young,et al.  A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. , 1983, Science.

[17]  P. Brennan,et al.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy , 1983, Infection and immunity.

[18]  R. Rees,et al.  Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. , 1983, Clinical and experimental immunology.

[19]  R. Golub,et al.  Chemiluminescence in microamounts of whole blood for investigation of the human phagocyte oxidative metabolism function. , 1982, Annales d'immunologie.

[20]  P. Brennan,et al.  A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity , 1981, Journal of bacteriology.